Brian Parkin

1.3k total citations
44 papers, 790 citations indexed

About

Brian Parkin is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Brian Parkin has authored 44 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 18 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Brian Parkin's work include Acute Myeloid Leukemia Research (18 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Multiple Myeloma Research and Treatments (10 papers). Brian Parkin is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Multiple Myeloma Research and Treatments (10 papers). Brian Parkin collaborates with scholars based in United States, Romania and Netherlands. Brian Parkin's co-authors include Sami N. Malek, Kerby Shedden, Peter Ouillette, Kamlai Saiya-Cork, Harry P. Erba, Nisar A. Amin, Shaomeng Wang, John Magenau, Pavan Reddy and Attaphol Pawarode and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Brian Parkin

39 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Parkin United States 16 374 317 212 200 198 44 790
Lisa Pleyer Austria 18 435 1.2× 369 1.2× 248 1.2× 204 1.0× 309 1.6× 53 947
Anna Jankowska United States 15 494 1.3× 390 1.2× 185 0.9× 188 0.9× 324 1.6× 27 939
Lisa Kujawski United States 13 255 0.7× 313 1.0× 164 0.8× 208 1.0× 359 1.8× 21 753
Sujiang Zhang China 13 368 1.0× 329 1.0× 149 0.7× 98 0.5× 223 1.1× 62 710
Fei Fei United States 14 229 0.6× 227 0.7× 241 1.1× 215 1.1× 113 0.6× 46 654
Afua A. Mensah Switzerland 15 309 0.8× 638 2.0× 173 0.8× 119 0.6× 143 0.7× 30 931
Swapna Thota United States 11 328 0.9× 269 0.8× 91 0.4× 116 0.6× 141 0.7× 55 621
Francesco Maura United States 18 580 1.6× 496 1.6× 315 1.5× 212 1.1× 205 1.0× 98 989
Ugo Consoli Italy 17 257 0.7× 367 1.2× 395 1.9× 239 1.2× 181 0.9× 36 863
Barbara Crescenzi Italy 18 476 1.3× 344 1.1× 207 1.0× 144 0.7× 235 1.2× 55 1.0k

Countries citing papers authored by Brian Parkin

Since Specialization
Citations

This map shows the geographic impact of Brian Parkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Parkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Parkin more than expected).

Fields of papers citing papers by Brian Parkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Parkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Parkin. The network helps show where Brian Parkin may publish in the future.

Co-authorship network of co-authors of Brian Parkin

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Parkin. A scholar is included among the top collaborators of Brian Parkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Parkin. Brian Parkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parkin, Brian, et al.. (2024). Venetoclax combined with hypomethylating agents for favorable risk acute myeloid leukemia: A single center experience.. Journal of Clinical Oncology. 42(16_suppl). e18514–e18514.
2.
3.
Green, Steven, Brian Parkin, Catherine Lai, Ivana Gojo, & Joshua F. Zeidner. (2023). AML-274 TAGALONG Trial: Phase II Study of Tagraxofusp and Azacitidine With or Without Venetoclax in Newly Diagnosed Secondary AML after Previous Exposure to Hypomethylating Agents. Clinical Lymphoma Myeloma & Leukemia. 23. S284–S284. 1 indexed citations
4.
Xu, Jintao, Bing He, Brian Parkin, et al.. (2022). Heterogeneity of neutrophils and inflammatory responses in patients with COVID-19 and healthy controls. Frontiers in Immunology. 13. 970287–970287. 16 indexed citations
5.
6.
Wang, Yin, Yan Liu, Christopher M. Bailey, et al.. (2020). Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin. Oncogene. 39(14). 3015–3027. 28 indexed citations
7.
Patel, Pritesh, et al.. (2020). Safety and efficacy of gemtuzumab ozogamicin and venetoclax in patients with relapsed or refractory CD33+ acute myeloid leukemia: A phase Ib study.. Journal of Clinical Oncology. 38(15_suppl). TPS7566–TPS7566. 2 indexed citations
8.
D’Souza, Anita, Parameswaran Hari, Marcelo C. Pasquini, et al.. (2019). A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation. 25(8). 1492–1497. 24 indexed citations
9.
Riwes, Mary, Alexander C. Schmidt, Thomas Braun, et al.. (2019). Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study. Blood. 134(Supplement_1). 3276–3276. 2 indexed citations
10.
Magenau, John, Steven C. Goldstein, Robert J. Soiffer, et al.. (2018). α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease. Blood. 131(12). 1372–1379. 83 indexed citations
11.
Parkin, Brian. (2018). Rare Variant Quantitation Using Droplet Digital PCR. Methods in molecular biology. 1881. 239–251. 6 indexed citations
12.
Pawarode, Attaphol, Anita D’Souza, Marcelo C. Pasquini, et al.. (2017). Phase 2 Study of Pembrolizumab during Lymphodepleted State after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Patients. Blood. 130. 339–339. 6 indexed citations
13.
Parkin, Brian, Angelina I. Londoño-Joshi, Qing Kang, et al.. (2017). Ultrasensitive mutation detection identifies rare residual cells causing acute myelogenous leukemia relapse. Journal of Clinical Investigation. 127(9). 3484–3495. 36 indexed citations
14.
Amin, Nisar A., Erlene Seymour, Kamlai Saiya-Cork, et al.. (2016). A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 22(17). 4525–4535. 52 indexed citations
15.
Parkin, Brian, Peter Ouillette, Mehmet Ali Yıldız, et al.. (2015). Integrated Genomic Profiling, Therapy Response, and Survival in Adult Acute Myelogenous Leukemia. Clinical Cancer Research. 21(9). 2045–2056. 17 indexed citations
16.
Pawarode, Attaphol, Shin Mineishi, Pavan Reddy, et al.. (2015). Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series. Biology of Blood and Marrow Transplantation. 22(1). 54–60. 10 indexed citations
17.
Magenau, John, Thomas Braun, Pavan Reddy, et al.. (2015). Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission. Annals of Hematology. 94(6). 1033–1041. 8 indexed citations
18.
Magenau, John, Peter Westervelt, Joseph P. McGuirk, et al.. (2014). Preliminary Data from a Multi-Center Study of Clofarabine / Busulfan Conditioning for Acute Myeloid Leukemia Not in Remission at Allogeneic Transplantation. Biology of Blood and Marrow Transplantation. 20(2). S155–S156. 1 indexed citations
19.
Saiya-Cork, Kamlai, Brian Parkin, Peter Ouillette, et al.. (2011). A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 17(9). 2679–2692. 27 indexed citations
20.
Ouillette, Peter, Brian Parkin, Li Ding, et al.. (2010). Aggressive Chronic Lymphocytic Leukemia with Elevated Genomic Complexity Is Associated with Multiple Gene Defects in the Response to DNA Double-Strand Breaks. Clinical Cancer Research. 16(3). 835–847. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Pleyer Breakdown of academic impact, for papers by Anna Jankowska Breakdown of academic impact, for papers by Lisa Kujawski Breakdown of academic impact, for papers by Sujiang Zhang Breakdown of academic impact, for papers by Fei Fei Breakdown of academic impact, for papers by Afua A. Mensah Breakdown of academic impact, for papers by Swapna Thota Breakdown of academic impact, for papers by Francesco Maura Breakdown of academic impact, for papers by Ugo Consoli Breakdown of academic impact, for papers by Barbara Crescenzi
Rankless by CCL
2026